Liang Zeng Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

5/2024	RET rearrangement as a mechanism of resistance to ALK-TKI in non-small cell lung cancer patient with EML4-ALK fusion: A case report.
10/2023	Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB-III non-small cell lung cancer patients using radiomic features.
6/2023	Intracranial activity of first-line immune checkpoint inhibitors combined with chemotherapy in advanced non-small cell lung cancer.
1/2023	Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With ROS1-Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study.
11/2022	Validation of E1L3N antibody for PD-L1 detection and prediction of pembrolizumab response in non-small-cell lung cancer.
11/2022	Exosomal protein angiopoietin-like 4 mediated radioresistance of lung cancer by inhibiting ferroptosis under hypoxic microenvironment.
9/2022	Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker study.
3/2022	Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements.
1/2022	Investigation on the survival implications of PD-L1 expression status in ALK- rearranged advanced non-small cell lung cancer treated with first-line crizotinib.
1/2022	Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liang Zeng Research Topics

Disease

78	Neoplasms (Cancer) 03/2024 - 08/2003
39	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2011
23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 12/2017
19	Nasopharyngeal Carcinoma 11/2023 - 06/2003
15	Adenocarcinoma of Lung 11/2023 - 01/2018
14	Lung Neoplasms (Lung Cancer) 05/2024 - 08/2003
12	Pain (Aches) 08/2018 - 01/2011
10	Inflammation (Inflammations) 02/2023 - 01/2020
9	Breast Neoplasms (Breast Cancer) 08/2023 - 02/2016
9	Carcinoma (Carcinomatosis) 05/2023 - 11/2006
7	Carcinogenesis 01/2019 - 02/2007
6	Colitis 03/2024 - 11/2019
6	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 04/2014
5	Infections 12/2023 - 04/2012
5	Glioma (Gliomas) 01/2023 - 09/2009
5	Brain Neoplasms (Brain Tumor) 01/2022 - 12/2011
4	Adenocarcinoma 03/2024 - 03/2018
4	Chronobiology Disorders (Circadian Rhythm Disorder) 01/2023 - 11/2021
4	Disease Progression 03/2022 - 01/2020
4	Lymphatic Metastasis 08/2019 - 07/2007
4	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 12/2014
4	Prion Diseases (Transmissible Spongiform Encephalopathies) 12/2016 - 01/2015
4	Chronic Disease (Chronic Diseases) 08/2014 - 10/2011
3	Lung Diseases (Lung Disease) 04/2024 - 08/2011
3	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2021
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 03/2013
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 09/2021
3	Colonic Neoplasms (Colon Cancer) 01/2013 - 04/2011
2	Rupture 09/2023 - 08/2003
2	Hemorrhage 09/2023 - 09/2006
2	Hypertension (High Blood Pressure) 01/2023 - 01/2022
2	Obesity 11/2022 - 11/2021
2	Hypothyroidism 07/2022 - 01/2022
2	Epistaxis (Nosebleed) 06/2022 - 05/2011
2	Neuroblastoma 01/2022 - 12/2016
2	COVID-19 09/2021 - 01/2021
2	Hyperplasia 01/2021 - 06/2013
2	Nausea 11/2018 - 03/2018
2	Vomiting 11/2018 - 03/2018

Drug/Important Bio-Agent (IBA)

37	Proteins (Proteins, Gene)FDA Link 07/2023 - 07/2004
16	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2011
11	TeaIBA 03/2024 - 01/2020
8	CrizotinibIBA 03/2022 - 01/2018
7	Tyrosine Kinase InhibitorsIBA 05/2024 - 01/2018
7	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2022
7	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 09/2007
6	ErbB Receptors (EGF Receptor)IBA 01/2022 - 09/2009
6	Messenger RNA (mRNA)IBA 09/2020 - 04/2011
5	CytokinesIBA 03/2024 - 08/2018
5	RNA (Ribonucleic Acid)IBA 01/2023 - 12/2020
5	Prion ProteinsIBA 12/2016 - 01/2015
4	pembrolizumabIBA 03/2024 - 01/2020
4	LipidsIBA 09/2022 - 07/2015
4	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2020 - 08/2015
3	Anaplastic Lymphoma KinaseIBA 05/2024 - 01/2022
3	Bile Acids and Salts (Bile Acids)IBA 03/2024 - 11/2021
3	LigandsIBA 12/2023 - 01/2019
3	AntibodiesIBA 12/2023 - 04/2015
3	osimertinibIBA 11/2023 - 01/2018
3	flotillinsIBA 08/2023 - 07/2015
3	Bevacizumab (Avastin)FDA Link 01/2022 - 01/2020
3	Phosphotransferases (Kinase)IBA 01/2022 - 09/2009
3	AfatinibIBA 01/2021 - 01/2018
3	Analgesics (Analgesic Drugs)IBA 07/2013 - 06/2011
3	Membrane Proteins (Integral Membrane Proteins)IBA 07/2008 - 08/2004
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 03/2024 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2013
2	Oxidoreductases (Dehydrogenase)IBA 02/2024 - 12/2017
2	MicroRNAs (MicroRNA)IBA 12/2023 - 02/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 01/2021
2	Mechanistic Target of Rapamycin Complex 1IBA 08/2023 - 01/2023
2	CholesterolIBA 08/2023 - 01/2023
2	Neurotransmitter Agents (Neurotransmitter)IBA 03/2023 - 05/2022
2	Serotonin (5 Hydroxytryptamine)IBA 03/2023 - 11/2019
2	Docetaxel (Taxotere)FDA Link 01/2023 - 09/2022
2	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 04/2022
2	PhytochemicalsIBA 01/2023 - 05/2022
2	PolyphenolsIBA 01/2023 - 01/2020
2	phosphoserine phosphataseIBA 01/2022 - 01/2022
2	EnzymesIBA 01/2022 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2012
2	Dextran SulfateIBA 09/2021 - 01/2020
2	anlotinibIBA 09/2021 - 06/2020
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 01/2015
2	AntiemeticsIBA 11/2018 - 03/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2018 - 07/2013
2	ParaffinIBA 10/2018 - 04/2018

Therapy/Procedure

40	Radiotherapy 11/2023 - 09/2006
37	Therapeutics 05/2024 - 08/2003
19	Drug Therapy (Chemotherapy) 03/2024 - 09/2007
7	Immunotherapy 12/2023 - 01/2021
7	Palliative Care (Palliative Therapy) 08/2014 - 10/2011
3	Neoadjuvant Therapy 03/2024 - 03/2018
3	Percutaneous Collagen Induction 01/2019 - 01/2015
3	Aftercare (After-Treatment) 07/2013 - 08/2003
2	Transplantation 03/2024 - 11/2017
2	Punctures 01/2023 - 09/2020
2	Combination Drug Therapy (Combination Chemotherapy) 01/2023 - 11/2018
2	Ligation 09/2020 - 08/2018